TrialAddiction (Abingdon, England)2021

Cost-effectiveness implications of increasing the efficiency of the extended-release naltrexone induction process for the treatment of opioid use disorder: a secondary analysis.

Sean M Murphy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.